ALZA CORP
10-Q, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: ALZA CORP, 10-Q, 2000-08-11
Next: AMERCO /NV/, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements included in Part I, Item 1 of Form 10-Q dated June 30, 2000
and is qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                             184
<SECURITIES>                                        80
<RECEIVABLES>                                      187
<ALLOWANCES>                                        20
<INVENTORY>                                         73
<CURRENT-ASSETS>                                   524
<PP&E>                                             576
<DEPRECIATION>                                     160
<TOTAL-ASSETS>                                   1,979
<CURRENT-LIABILITIES>                              118
<BONDS>                                            951
                                0
                                          0
<COMMON>                                             1
<OTHER-SE>                                         825
<TOTAL-LIABILITY-AND-EQUITY>                     1,979
<SALES>                                            243
<TOTAL-REVENUES>                                   455
<CGS>                                               77
<TOTAL-COSTS>                                      169
<OTHER-EXPENSES>                                    72
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  31
<INCOME-PRETAX>                                    110
<INCOME-TAX>                                        34
<INCOME-CONTINUING>                                 76
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                        76
<EPS-BASIC>                                       0.74
<EPS-DILUTED>                                     0.72


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission